Introduction
============

Uveitis is a frequent extra-articular manifestation of chronic inflammatory joint diseases and may be the first symptom of rheumatic disease.

Aim
===

To analyze all patients with uveitis attended by a tertiary hospital during one-year period and the treatment administered, with special attention paid to cases of uveitis associated with rheumatic diseases.

Patients and methods
====================

We analyzed all patients with uveitis attended by our ophthalmology outpatient clinic from January to December 2009 and also recorded the percentage of first visits.

The data collected were: age, gender, type of uveitis (anterior, intermediate, posterior, panuveitis), diagnosis (associated with rheumatic diseases, infectious uveitis, ophthalmologic-specific conditions and idiopathic uveitis) and the treatment received (glucocorticoids, biological therapy, immunosuppressive therapy, surgery).

Results
=======

314 patients with uveitis (60% female, mean age 47.6 ± 18.3 years (range 6- 87 years)) were attended during the study period: it was the first visit in 32% patients. According to the anatomical site, 102 patients (33%) had anterior uveitis, 33 (11%) intermediate uveitis, 110 (35%) posterior uveitis and 69 (22%) panuveitis. According to the diagnosis, 89 patients (28%) had uveitis associated with rheumatic disease, 88 (28%) infectious uveitis, 54 (17%) ophthalmologic-specific conditions and 83 (26%) idiopathic uveitis. The most-frequent associated rheumatic diseases were: 25 patients (28%) with Behçet disease; 18 (20%) with HLAB27+ ankylosing spondylitis; 14 (18%) with sarcoidosis; 7 (8%) with juvenile idiopathic arthritis and 6 (7%) with systemic lupus erythematosus. Thirty-one patients received biological therapy with anti-TNF-alpha (most-frequently those with Behçet disease and juvenile idiopathic arthritis), 26 immunosuppressive therapy and 23 required surgery.

Conclusion
==========

Rheumatic conditions were a common cause of uveitis in our patients. The most-frequent were Behçet's disease, HLAB27+ ankylosing spondylitis, sarcoidosis and juvenile idiopathic arthritis. Biological therapy is administered in a significant proportion of patients with uveitis, mainly those with Behçet disease and juvenile idiopathic arthritis.
